n-monodemethyldiltiazem has been researched along with nadp in 1 studies
| Studies (n-monodemethyldiltiazem) | Trials (n-monodemethyldiltiazem) | Recent Studies (post-2010) (n-monodemethyldiltiazem) | Studies (nadp) | Trials (nadp) | Recent Studies (post-2010) (nadp) |
|---|---|---|---|---|---|
| 30 | 3 | 1 | 21,608 | 25 | 3,484 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gorski, JC; Hall, SD; Hamman, MA; Jones, DR; Mayhew, BS; Rider, S | 1 |
1 other study(ies) available for n-monodemethyldiltiazem and nadp
| Article | Year |
|---|---|
Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Calcium Channel Blockers; Catalysis; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diltiazem; Enzyme Inhibitors; Humans; Kinetics; Methylation; Microsomes, Liver; NADP; Oxidoreductases, N-Demethylating | 1999 |